Related Experiment Video

Updated: Jun 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Antiretroviral drugs in HIV-infected children

Alessandra Viganò, Valeria Manfredini, Francesca Penagini

    Pharmacological Research
    |January 25, 2011
    PubMed

    Insights

    Highly active antiretroviral therapy has transformed HIV infection into a manageable chronic condition for children. This review details current advances in pediatric HIV treatment, addressing adherence, toxicity, and resistance challenges.

    Area of Science:

    • Pediatric Infectious Diseases
    • Virology
    • Clinical Pharmacology

    Background:

    • Antiretroviral therapy (ART) has shifted HIV from a fatal illness to a chronic condition in children.
    • Pediatric HIV management presents unique challenges including regimen selection, adherence, and toxicity.
    • Emergence of drug resistance is a significant concern in long-term pediatric HIV care.

    Discussion:

    • Optimizing ART regimens for children requires careful consideration of efficacy and safety profiles.
    • Strategies to improve long-term adherence to antiretroviral therapy are crucial for sustained viral suppression.
    • Monitoring and managing short- and long-term toxicities associated with pediatric ART are essential.
    • Addressing the growing issue of extensive drug resistance in pediatric HIV is a priority.

    Key Insights:

    • Current ART regimens offer improved survival and quality of life for HIV-infected children.
    • Adherence remains a critical factor for successful long-term management of pediatric HIV.
    • Understanding and mitigating drug-related toxicities are vital for pediatric patient well-being.
    • Combating the development of drug resistance is key to preserving future treatment options.

    Outlook:

    • Further research into novel antiretroviral agents and treatment strategies for children is ongoing.
    • Personalized medicine approaches may offer tailored ART regimens for pediatric HIV patients.
    • Global efforts to improve access to and adherence of pediatric ART are essential.
    • Continued vigilance against drug resistance will shape future pediatric HIV treatment guidelines.

    More Related Videos

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
    Inhibitors of Virion Maturation and Assembly01:19

    Inhibitors of Virion Maturation and Assembly

    As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...